News search

A new study led by the CNIC has identified imidazole propionate (ImP), a metabolite produced by gut bacteria, as a driver of atherosclerosis— as a driver of atherosclerosis, the disease behind most heart attacks and strokes

CNIC researchers have uncovered the evolutionary logic of the OxPhos system—the cell’s “engine”—and developed a tool to detect mutations that cause mitochondrial disease

The projects—led by Drs Almudena Ramiro, José Antonio Enríquez, and Silvia Priori—will receive a total of €5.25 million for CNIC research over the next 5 years

This new tool will advance the development of treatments for congenital muscle diseases and cardiomyopathies. 

Dr. Joseph Hill holds the James T. Willerson, M.D., Chair in Cardiovascular Disease and the Frank M. Ryburn Jr. Chair in Cardiac Research at the University of Texas Southwestern Medical Center

Dra. Maria Kontaridis currently serves as the Gordon K. Moe Professor and Chair of Biomedical Research and Translational Medicine, as well as is the Executive Director and Director of Research, at the Masonic Medical Research Institute

Dr. Mariell Jessup is Chief Science and Medical Officer of the American Heart Association